What's happening
This bill requires health insurance policies in New York to fully cover multi-marker testing for ovarian cancer in patients diagnosed with an ovarian adnexal mass, with no deductibles or coinsurance.
Why it matters
Removes financial barriers for critical diagnostic testing. By prohibiting deductibles and coinsurance for multi-marker ovarian cancer testing after an adnexal mass diagnosis, the bill ensures that patients do not delay or forgo potentially life-saving tests due to out-of-pocket costs.
Promotes early and accurate detection of ovarian cancer. Multi-marker testing can improve diagnostic accuracy compared to single-marker tests, leading to earlier intervention and potentially better treatment outcomes for individuals at risk.
Standardizes coverage across insurance types, including Medicaid. The bill mandates equal coverage for this testing across individual, group, blanket, and public (Medicaid) insurance plans, reducing disparities in access to advanced diagnostics regardless of income or insurance status.
Could influence broader insurance policy trends. Requiring insurers to fully cover advanced cancer diagnostics without cost-sharing may set a precedent for similar mandates in other states or for other high-impact medical tests, shaping future health policy.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Require Ovarian Cancer Test Coverage
Plain English, a few words. Used as the page title.
Sponsors
No co-sponsors yet.
History
- Referred to insurance
- Referred to insurance
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Require Insurers Cover Ovarian Testing
In Senate Committee · Insurance · Sponsor Roxanne J. Persaud
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
6186
2023-2024 Regular Sessions
IN ASSEMBLY
April 3, 2023
Introduced by M. of A. HUNTER -- read once and referred to the Committee on Insurance
AN ACT to amend the insurance law and the social services law, in relation to requiring health insurance policies to fully cover multimarker testing related to ovarian cancer to patients which have been diagnosed with an ovarian adnexal mass
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subsection (i) of section 3216 of the insurance law is amended by adding a new paragraph 11-c to read as follows:
(11-c) (A) Every policy that provides coverage for hospital, surgical or medical care shall offer full coverage for multi-marker testing related to ovarian cancer to patients which have been diagnosed with an ovarian adnexal mass.
(B) Such additional coverage shall not be subject to annual deductibles and coinsurance but shall be borne solely by the insurer.
§ 2. Subsection (l) of section 3221 of the insurance law is amended by adding a new paragraph 11-c to read as follows:
(11-c) (A) Every insurer delivering a group or blanket policy or issuing a group or blanket policy for delivery in this state that provides coverage for hospital, surgical or medical care shall offer full coverage for multi-marker testing related to ovarian cancer to patients which have been diagnosed with an ovarian adnexal mass.
(B) Such additional coverage shall not be subject to annual deductibles and coinsurance but shall be borne solely by the insurer.
§ 3. Section 4303 of the insurance law is amended by adding a new subsection (p-1) to read as follows:
(p-1) (1) A medical expense indemnity corporation, a hospital service corporation or a health service corporation that provides coverage for hospital, surgical or medical care shall offer full coverage for multi-
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD07245-01-3
marker testing related to ovarian cancer to patients which have been diagnosed with an ovarian adnexal mass.
(2) Such additional coverage shall not be subject to annual deductibles and coinsurance but shall be borne solely by the insurer.
§ 4. Subdivision 2 of section 365-a of the social services law is amended by adding a new paragraph (kk) to read as follows:
(kk) multi-marker testing related to ovarian cancer to patients which have been diagnosed with an ovarian adnexal mass.
§ 5. This act shall take effect on the first of January next succeeding the date on which it shall have become a law and shall apply to policies issued, reissued, renewed, modified or amended on or after such date.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.